or Try an Advanced Search...

    Technical Analysis for IPSC - Century Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.26 9.57% 0.11
    IPSC closed up 9.57 percent on Friday, November 1, 2024, on 1.18 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IPSC trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 9.57%
    Lower Bollinger Band Walk Weakness 9.57%
    New 52 Week Low Weakness 9.57%
    Wide Bands Range Expansion 9.57%
    Below Lower BB Weakness 9.57%
    Down 3 Days in a Row Weakness 9.57%
    Older End-of-Day Signals for IPSC ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 21 hours ago
    Up 1 ATR about 21 hours ago
    Up 10% about 22 hours ago
    60 Minute Opening Range Breakout about 23 hours ago
    Rose Above Lower Bollinger Band about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IPSC Chart by TradingView
    Basic chart:

    Profile

    Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provides an opportunity to advance the course of cancer care.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Biology Stem Cell Cell Therapy Cell Biology Induced Stem Cells Cancer Care Cloning

    Is IPSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate
    Oct 22 electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?
    Sep 26 Century Therapeutics taps Morgan Conn as CFO
    Sep 26 Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
    Aug 8 Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates
    Aug 8 Century Therapeutics GAAP EPS of -$0.38, revenue of $0.8M
    Aug 8 Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
    Jul 12 After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain
    Jul 9 Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
    Jun 20 Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101
    See more IPSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.51
    52 Week Low 1.14
    Average Volume 357,882
    200-Day Moving Average 2.87
    50-Day Moving Average 1.55
    20-Day Moving Average 1.45
    10-Day Moving Average 1.40
    Average True Range 0.13
    RSI (14) 37.50
    ADX 16.98
    +DI 13.00
    -DI 27.12
    Chandelier Exit (Long, 3 ATRs) 1.27
    Chandelier Exit (Short, 3 ATRs) 1.52
    Upper Bollinger Bands 1.68
    Lower Bollinger Band 1.21
    Percent B (%b) 0.1
    BandWidth 32.25
    MACD Line -0.09
    MACD Signal Line -0.06
    MACD Histogram -0.027
    Fundamentals Value
    Market Cap 75.39 Million
    Num Shares 59.8 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -0.57
    Price-to-Sales 103.41
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.49
    Resistance 3 (R3) 1.48 1.39 1.45
    Resistance 2 (R2) 1.39 1.34 1.40 1.43
    Resistance 1 (R1) 1.33 1.30 1.36 1.34 1.42
    Pivot Point 1.24 1.24 1.26 1.25 1.24
    Support 1 (S1) 1.18 1.19 1.21 1.19 1.10
    Support 2 (S2) 1.09 1.15 1.10 1.09
    Support 3 (S3) 1.03 1.09 1.07
    Support 4 (S4) 1.04